Dose Dependency of Iatrogenic Glucocorticoid Excess and Adrenal Insufficiency and Mortality: A Cohort Study in England
Open accessThe DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
CONTEXT: Adrenal insufficiency and Cushing syndrome are known adverse events of glucocorticoids. However, no population estimates of dose-related risks are available. OBJECTIVE: To investigate dose-related risks of adrenal dysfunction and death in adults with six chronic inflammatory diseases treated with oral glucocorticoids. DESIGN AND SETTING: Retrospective, record-linkage, open-cohort study spanning primary and hospital care in England. PATIENTS: A total of 70,638 oral glucocorticoid users and 41,166 nonusers aged ≥18 years registered in 389 practices in 1998 to 2017. MAIN OUTCOME MEASURES: Incidence rates and hazard ratios (HRs) of diagnosed adrenal dysfunction and death. RESULTS: During a median follow-up of 5.5 years, 183 patients had glucocorticoid-induced adrenal insufficiency and 248 had glucocorticoid-induced Cushing syndrome. A total of 22,317 (31.6%) and 7544 (18.3%) deaths occurred among glucocorticoid users and nonusers, respectively. The incidence of all outcomes increased with higher current daily and cumulative doses. For adrenal insufficiency, the increases in HRs were 1.07 (95% CI: 1.04 to 1.09) for every increase of 5 mg per day and 2.25 (95% CI: 2.15 to 2.35) per 1000 mg of cumulative prednisolone-equivalent dose over the past year. The respective increases in HRs for Cushing syndrome were 1.09 (95% CI: 1.08 to 1.11) and 2.31 (95% CI: 2.23 to 2.40) and for mortality 1.26 (95% CI: 2.24 to 1.28) and 2.05 (95% CI: 2.04 to 2.06). CONCLUSION: We report a high glucocorticoid dose-dependent increased risk of adrenal adverse events and death. The low observed absolute risk of adrenal insufficiency highlights a potential lack of awareness and a need for increased physician and patient education about the risks of adrenal dysfunction induced by glucocorticoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1. Study flow diagram and outcome identification. Eligibility inclusion criteria were a minimum of 1 year of registration in the CPRD practice, consent to data linkage, age ≥18 years, and a diagnosis of inflammatory bowel disease, systemic lupus erythematosus, polymyalgia rheumatica, giant cell arteritis, rheumatoid arthritis, and/or vasculitis before or during the study period (1 January 1998 to 15 March 2017). During periods of nonglucocorticoid exposure, 102 patients had adrenal insufficiency and 94 patients had Cushing syndrome diagnosed at a median of 52 [interquartile range (IQR): 31 to 79] d and 42 (IQR: 30 to 63) d, respectively, following glucocorticoid discontinuation. ADI, adrenal insufficiency; CS, Cushing syndrome; GC, glucocorticoid.](https://figures.cochat.ai/paper-figures/e3412e1e628f4e5facf03cf93ae21af9/dose-dependency-of-iatrogenic-glucocorticoid-excess-and-adrenal-insufficiency-figure-1.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another study found a sharp mortality increase in the first 3-6 months after cessation of long-term oral glucocorticoids (29).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [29]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A retrospective cohort study from the United Kingdom including 70 638 oral glucocorticoid users found a sharp increase in the incidence of mortality during the first 2 months after glucocorticoid cessation, which then rapidly decreased after the first 3 months.”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“Whilst only 13 subjects had their cause of death recorded as adrenal insufficiency, the relationship with glucocorticoid cessation raises the suspicion of possible undiagnosed adrenal crises (29).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“The use of supraphysiologic glucocorticoids (prednisone equivalent dose > 5 mg daily) has been associated with a higher risk of all-cause mortality (adjusted hazard ratio of 1.97 (95% CI 1.81-2.15) in rheumatoid arthritis patients (30), with increasing risk with higher current daily and cumulative doses (29, 31).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“Based on a retrospective analysis mortality is increased particularly in the immediate period following the cessation of glucocorticoid therapy (29).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [29]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimating the Dimension of a Model
Schwarz, G. (1978) · The Annals of Statistics · doi:10.1214/aos/1176344136 · Cited by 47,033
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
Multiple imputation using chained equations: Issues and guidance for practice
White, I. R., Royston, P., & Wood, A. M. (2011) · Statistics in Medicine · doi:10.1002/sim.4067 · Cited by 9,792 · cited 1×
“The number of data sets to be imputed was assumed to be at least 100 times the fraction of incomplete cases (19).”
BackgroundCausal Diagrams for Epidemiologic Research
Greenland, S., Pearl, J., & Robins, J. M. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00008 · Cited by 3,728
Air Pollution and Hospital Admissions for Heart Disease in Eight U.S. Counties
Schwartz, J. (1999) · Epidemiology · doi:10.1097/00001648-199901000-00005 · Cited by 3,038
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Herrett, E., Gallagher, A. M., Bhaskaran, K., Forbes, H., Mathur, R., van Staa, T., & Smeeth, L. (2015) · International Journal of Epidemiology · doi:10.1093/ije/dyv098 · Cited by 2,667 · cited 7×
“Fourth, prescribed medications are automatically recorded in the CPRD, minimizing recording errors.”
MethodInfluentialA multivariate technique for multiply imputing missing values using a sequence of regression models
Raghunathan, T. E., Lepkowski, J. M., Hoewyk, J. V., & Solenberger, P. W. (2001) · Survey methodology · Cited by 2,436
Overadjustment bias and unnecessary adjustment in epidemiologic studies.
Schisterman, E. F., Cole, S. R., & Platt, R. W. (2009) · Epidemiology · doi:10.1097/ede.0b013e3181a819a1 · Cited by 2,096 · cited 2×
“3) Erythrocyte sedimentation rate, mm/h 17 (24) 13 (21) Comorbidities, n (%) Asthma 18,217 (25.”
Method(2003) · RePEc: Research Papers in Economics · Cited by 1,844
Cited by
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Naringenin: A flavanone with anti-inflammatory and anti-infective properties
Cai, J., Wen, H., Zhou, H., Zhang, D., Lan, D., Liu, S., Li, C., Dai, X., Song, T., Wang, X., et al. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114990 · Cited by 190
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Lockett, J., Inder, W. J., & Clifton, V. L. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae008 · Cited by 135
Metadata
- Authors
- Mebrahtu, T. F., Morgan, A. W., Keeley, A., Baxter, P. D., Stewart, P. M., & Pujades-Rodriguez, M.
- Affiliations
- University of Leeds (GB)
- Leeds Institute of Health Sciences, School of Medicine, University of Leeds, Leeds, United Kingdom
- ORCID
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2019-04-22
- Volume
- 104
- Issue
- 9
- Pages
- 3757-3767
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- PMC
- PMC6656418
- OpenAlex
- W2941172693
- Cited by
- 75
- References
- 35
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 12 · 2023: 12 · 2022: 8 · 2021: 10 · 2020: 17 · 2019: 4
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Clinical Endocrinology & Metabolism (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Medical Research Council (RO-115-2018-1061)
- European Research Council (250271)
- National Institute for Health Research (RGRMEX 107713, MIC-2016-015, NF-SI-0514-10090)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- glucocorticoid-induced adrenal insufficiency, dose-dependent risk, mortality, chronic inflammatory diseases, prednisolone-equivalent dose, cumulative glucocorticoid dose, adverse drug reactions, adrenal dysfunction, England, primary and hospital care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Dose Dependency of Iatrogenic Glucocorticoid Excess and Adrenal Insufficiency and Mortality: A Cohort Study in England. https://app.cochat.ai/papers/10.1210/jc.2019-00153
- The paper
- Mebrahtu, T. F., Morgan, A. W., Keeley, A., Baxter, P. D., Stewart, P. M., & Pujades-Rodriguez, M. (2019). Dose Dependency of Iatrogenic Glucocorticoid Excess and Adrenal Insufficiency and Mortality: A Cohort Study in England. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2019-00153
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.